Modern markers in diagnostics of atherosclerosis

Cherepakhin D.I.; Basylev V.V.; Evtiushkin I.A.; Suchkov S.V.; Bogopol'skaia O.M.; Charchian É.R.; Belov Yu.V.; Pal'tsev M.A.

doi:https://doi.org/

Cherepakhin D.I.

Pervyĭ MGMU im. I.M. Sechenova, Moskva

Basylev V.V.

Federal Center for Cardiovascular Surgery under Ministry of Health of the Russian Federation, 440071, Penza, Russia

Evtiushkin I.A.

FTsSSKh, Penza

Suchkov S.V.

Pervyĭ MGMU im. I.M. Sechenova, Moskva

Bogopol'skaia O.M.

FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Charchian É.R.

RNTsKh im. akad. B.V. Petrovskogo RAMN

SPIN RSCI: 4641-0523
Scopus AuthorID: 14044681400
ORCID: 0000-0002-0488-2560

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

SPIN RSCI: 2740-1439
Scopus AuthorID: 7101862336
ResearcherID: 7101862336
ORCID: 0000-0002-9280-8845

Pal'tsev M.A.

NITs "Kurchatovskiĭ institut", Moskva

Modern markers in diagnostics of atherosclerosis

Authors:

Cherepakhin D.I., Basylev V.V., Evtiushkin I.A., Suchkov S.V., Bogopol'skaia O.M., Charchian É.R., Belov Yu.V., Pal'tsev M.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(3): 26‑29

Read: 5422 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Cherepakhin DI, Basylev VV, Evtiushkin IA, et al. Modern markers in diagnostics of atherosclerosis. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(3):26‑29. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

References:

Vizir V.A., Berezin A.E. Immunovospalitel'naya aktivatsiya kak kontseptual'naya model' formirovaniya i progressirovaniya serdechnoi nedostatochnosti. Ter arkh 2000; 4: 77-80.
Vel'kov V.V. S-reaktivnyi belok i lipoprotein-assotsiirovannaya fosfolipaza A2: Novye fakty i novye vozmozhnosti dlya diagnostiki i stratifikatsii serdechno-sosudistykh riskov. Klin-lab konsilium 2009; 6: 28-33.
Volkov V.I., Kalashnik D.N., Serik S.A. Izmenenie urovnya matriksnoi metalloproteinazoi-9 u bol'nykh so stabil'noi i nestabil'noi stenokardiei. Ukrainskii terapevticheskii zhurn 2006; 1: 4-7.
Dati F., Mettsman E. Belki. Laboratornye testy i klinicheskoe primenenie. M: Labora 2007; 303-312.
Zemlyanskaya O.A. Rol' matriksnykh metalloproteinaz v razvitii restenozov posle chreskozhnykh koronarnykh vmeshatel'stv. Angiol i sosud khir 2009; 1: 29-35.
Kosareva P.V., Limanskii A.S., Zimushkina N.A. Ekspressiya ICAM-1, proapopticheskogo belka FAS LIGAND i regulyatornogo proteina KI-67 v tkani pochek eksperimental'nykh zhivotnykh pri modelirovanii stafilokokkovogo pielonefrita. Sovremennye problemy nauki i obrazovaniya 2009; 6: 83-83.
Materialy Mezhdunarodnoi Federatsii klinicheskoi khimii i laboratornoi meditsiny Insbruk, Avstriya, 7-11 iyunya 2009 g. Klin-lab konsilium 2009; 5: 73-79.
Nazarov P.G. Pentraksiny v reaktsiyakh vrozhdennogo i priobretennogo immuniteta, organizatsii matriksa, fertil'nosti. Med akad zhurn 2010; 4: 107-124.
Nikolaev N.A., Bunova S.S., Nelidova A.V. i dr. Mezhkletochnye molekuly adgezii sicam-1 v diagnostike doklinicheskogo ateroskleroza u bol'nykh arterial'noi gipertoniei bez metabolicheskikh narushenii. Fundamental'nye issledovaniya 2008; 1: 109-110.
Pigarevskii P.V. Antigeny i ikh rol' v immunovospalitel'nykh reaktsiyakh pri aterogeneze u cheloveka. Med akad zhurn 2010; 4: 210-217.
Stokle Zh.-K., Myulle B., Andriantsitokhaina R., Kleshchev A. Giperproduktsiya oksida azota v patofiziologii krovenosnykh sosudov. Biokhimiya 1998; 7: 76-83.
Cooke J.P. Role of nitric oxide in progression and regression of atherosclerosis. West J Med 1996; 164: 419-424.
Cracowski J.L., Stanke-Labesque F., Bessard G. Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects. Rev Med Int 2000; 21: 304-307.
Lentz S.R., Haynes W.G. Homocysteine: Is it a clinically important cardiovascular risk factor? Clev Clin J Med 2004; 71: 729-734.
Mykkanen L., Zaccaro D.J., Hales C.N. et al. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 1999; 42: 1060-1066.
Nagi D.K., Hendra T.J., Ryle A.J. et al. The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1990; 33: 532-537.
Ocmar B.S., Tschudi M.R., Godoy N. et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97: 2494-2498.
Potter K. Homocysteine and cardiovascular disease: should we treat? Clin Biochem Rev 2008; 29: 27-30.
Rearson T.A., Mensah G.A., Alexander R.W. et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation 2003; 107: 499-511.
Roberts L.J., Morrow J.D. Measurement of F2-isoprostanesas an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 4: 505-513.
Tietz W. Clinical guide to laboratory tests. 4-th ed. Ed. Wu A.N.B. USA: W.B. Sounders Company 2006; 1798.
Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk. J Appl Genet 2008; 49: 267-282.